Patient No | Age (years) | Disease duration (years) | Anti-CCP antibodies (IU/ml) | Synovitis (Y/N) | Systemic manifestation | Serum IgG (g/l) | RF | Anti-Ro | Anti-La | Focus score >1 | ACR criteria for RA (n) |
---|---|---|---|---|---|---|---|---|---|---|---|
Anti-CCP, anti-cyclic citrullinated peptide antibodies; RF, rheumatoid factor; ACR, American College of Rheumatology; RA, Rheumatoid Arthritis; ND, not done. | |||||||||||
1 | 66 | 9 | 137 | N | Arthalgia, Raynaud’s phenomenon | ND | – | + | – | + | 0 |
2 | 59 | 14 | 181 | Y | Arthritis, thyroiditis | ND | + | – | – | + | 3 |
3 | 37 | 6 | 185 | N | Raynaud’s phenomenon | ND | + | + | – | + | 1 |
4 | 53 | 10 | 124 | Y | Arthritis | 1.2 | + | – | – | + | 3 |
5 | 82 | 24 | 171 | N | Arthralgia, skin vasculitis, thyroiditis | 9.6 | + | – | – | + | 1 |
Mean (SD) | 59.4 (16.6) | 12.6 (7) | 159.6 (27.4) | 2/5 | 4/5 | 2/5 | 0/5 | 5/5 |